STAT+: Trump releases health care plan amid pressure over affordability
Trump's most consequential proposals would require action from Congress.
Health
STAT+: Former Emergent BioSolutions CEO sued for insider trading, company reaches $900K settlement in N.Y.
The former CEO of Emergent BioSolutions was accused of insider trading by the New York State attorney general in connection with a Covid-era contract.
Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial Mandated
New Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of permission to Johnson & Johnson Pvt. Ltd. to import and market…
Diabetes risk not associated with timing or type of menopause: Study
Women aged younger than 45 years who experience menopause are at a higher risk of coronary heart disease and stroke. However, despite such diabetes-related risk factors as increased fat and…
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy: Study
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the…
Subcutaneous Anifrolumab Improves Outcomes in Systemic Lupus Erythematosus: Phase 3 trial
Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with systemic lupus erythematosus (SLE). In the phase 3 TULIP-SC trial, anifrolumab met its primary BICLA endpoint…
Sleeping less than 7 hours could cut years off your life, reveals study
Getting a full night of sleep may play a larger role in longevity than many people realize. New research from Oregon Health & Science University indicates that regularly getting too…
Cardiovascular Risk Score Predicts Future Serious Eye Disease Risk: Study
USA: A new study, published in Ophthalmology, has revealed that the Pooled Cohort Equations cardiovascular risk score—which integrates age, sex, blood pressure, cholesterol levels, and smoking status to estimate 10-year…
FDA Approves First At-Home Brain Neuromodulation Device for Depression
The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment for adults whose depression has not responded adequately to antidepressants. Developed by Neurolief, the…
Rosuvastatin Shows Cardiovascular Edge but Higher Albuminuria Risk in Diabetic CKD: Study Shows
China: A large real-world study from Hong Kong suggests that rosuvastatin and atorvastatin have comparable effects on progression to end-stage kidney disease (ESKD) in Chinese patients with diabetes. While rosuvastatin…